• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS II
Device Problems Device Displays Incorrect Message (2591); Device Operates Differently Than Expected (2913); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Date 09/13/2016
Event Type  Injury  
Event Description
Leica biosystems received a complaint that tissue in 167 cassettes processed showed poor morphology.The complainant reported that tissue was falling from the blocks; specimens were floating in the molds; the tissue samples were brittle and hard to cut; no errors had been displayed during processing; batch controls for haematoxylin and eosin were satisfactory and errors occurred during the cleaning cycle for retort b, which failed.On 22 september 2016, leica biosystems received information that seven (7) patients had been recommended for re-biopsy.An identifier, the age and the gender were provided for each of the patients recommended for re-biopsy.Refer to # 8020030-2016-00068; 8020030-2016-00070; 8020030-2016-00071; 8020030-2016-00072; 8020030-2016-00073; and 8020030-2016-00074 for specific details of the other patients involved.
 
Manufacturer Narrative
Investigation of this complaint found that: - the sub-optimal tissue processing reported by the complainant was derived from "5hr run" protocol started in retort b at 20:06pm on (b)(6) 2016, which comprised 168 cassettes, and completed successfully at 04:00am on (b)(6) 2016.- the reagent in bottles 4 (70% ethanol) and 12 (xylene) had been replaced prior to commencement of the "5hr run" protocol started in retort b at 20:06pm on (b)(6) 2016.No use error(s) was identified in the instrument logs in the interaction between the user and the instrument when completing manual replacement of either of the reagents.- the reagent in bottles 4 (70% ethanol) and 12 (xylene) was used for the first time in the second dehydration and the final clearing steps respectively of the "5 hr run" protocol started in retort b at 20:06pm on (b)(6) 2016.- the instrument was found to have operated within specification during execution of the "5hr run" protocol started in retort b at 20:06pm on (b)(6) 2016.The root cause of the sub-optimal tissue processing reported from the "5hr run" protocol started in retort b at 20:06pm on (b)(6) 2016 could not be determined from the information available.The root cause for failure of the cleaning cycle, which was run subsequent to completion of the "5hr run" protocol started in retort b at 20:06pm on (b)(6) 2016 from which the sub-optimal tissue processing was reported by the complainant, was a high level of contamination of the reagent in bottle 15 (cleaning xylene) with floating solid material.The specific composition of the floating solid material could not be determined from the instrument logs.Failure of the cleaning cycle is not considered to have either caused or contributed to the sub-optimal tissue processing reported.A leica field service engineer arranged for the contents of bottle 15 (cleaning xylene) to be replaced during attendance at the customer site on 14 september 2016; and subsequently verified that there was no remnant blockage in the instrument by performing the appropriate service tests.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, victoria 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, victoria 3149
AS   3149
92117535
MDR Report Key6078041
MDR Text Key59119412
Report Number8020030-2016-00069
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberPELORIS II
Device Catalogue Number26.0008
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/21/2012
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age37 YR
-
-